FUSIONGENOMICS is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing.
Our ONETest™ products, in combination with our FUSIONCloud™ data analysis platform, enable rapid identification of the genetic signatures of human pathogens and cancers accurately and economically.
FUSION’sONETest™ platform is currently being tested at various key opinion leaders in Canada and the European Union.
Investors interested in discussing backing for FUSION GENOMICS, please Contact us.
